Journal of the National Comprehensive Cancer Network · 2020 · 564 citations · 223 references
MedicineOncologyRadiation OncologyNeuro-oncologyNeuroradiologySurgical OncologyBrain MetastasesBrain Metastasis ManagementBrain TumorsCentral Nervous System TumorsMetastatic Brain TumorsNeuro-oncologic ImagingBrain Tumor DiagnosisBrain Tumor PathologyCentral Nervous System Tumor ImagingDiagnosis Of Brain MetastasesGlioma SurgeryHistopathology Of Brain TumorsMetastatic Disease StagingStandard Of Practice
The NCCN Guidelines for adult CNS cancers emphasize interdisciplinary care and integrated histopathologic and molecular tumor characterization to guide management across a spectrum from pilocytic astrocytoma to metastatic brain disease. This article outlines NCCN recommendations for WHO grade I–IV gliomas and treatment of brain metastases.
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.
223
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text